IMHO we shouldnt be worry about the IND FDA approval we should be focused on the company's growth, market cap and REVENUES at this point. Everything Else is already a given.
The new merger is the right vehicle to take ESCOZINE to the open market in the US and give it exposure with new branding, endorsements and packaging.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.